Maximum quantity allowed is 999
Please select the quantity
CAS RN: 154598-52-4 | Product Number: E0997
Efavirenz
×
![]()
×
Purity: >98.0%(HPLC)(N)
Synonyms:
- (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 5G |
NT$3,654
|
9 | 38 | Contact Us |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
| Product Number | E0997 |
| Purity / Analysis Method | >98.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | C__1__4H__9ClF__3NO__2 = 315.68 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (<0°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 154598-52-4 |
| Reaxys Registry Number | 7387333 |
| PubChem Substance ID | 253660107 |
| Merck Index (14) | 3521 |
| MDL Number | MFCD05662344 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 98.0 % |
| Melting point | 136.0 to 140.0 °C |
| Specific rotation [a]20/D | -93.0 to -98.0 deg(C=1,MeOH) |
Properties (reference)
| Melting Point | 138 °C |
| Specific Rotation | -95° (C=1,MeOH) |
| Maximum Absorption Wavelength | 247 nm (MeOH) |
| Solubility in water | Insoluble |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. H413 : May cause long lasting harmful effects to aquatic life. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| RTECS# | DM3440000 |
Transport Information:
| H.S.code* | 2934.99-000 |
Application
Efavirenz: a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Efavirenz is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) which shows good inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT). RT is an essential viral enzyme which transcribes viral RNA into DNA. Compared with first-generation NNRTIs such as nevirapine [N0922], efavirenz shows greater resilience to drug resistance mutations within HIV-1 RT. Efavirenz is not effective against HIV-2 RT and human DNA polymerase.
References
- Efavirenz
- Structural Basis for the Resilience of Efavirenz (DMP-266) to Drug Resistance Mutations in HIV-1 Reverse Transcriptase
- The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism:Implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity
- Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance
- The history of antiretrovirals: key discoveries over the past 25 years
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.